We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Elevated blood microplastics and their potential association with Parkinson’s disease
Summary
Researchers collected blood samples from 21 Parkinson's disease patients and 12 healthy controls and found that patients with Parkinson's had significantly higher levels of microplastics in their blood. The Parkinson's patients also reported more frequent use of disposable plastic products and bottled water, suggesting greater environmental exposure. The study provides early evidence of a potential association between blood microplastic levels and Parkinson's disease, though further research is needed to understand any causal relationship.
Microplastic (MP) contamination in human blood and its potential link to Parkinson's disease (PD) remain poorly understood. In this study, we collected whole blood samples from 21 PD patients and 12 age- and sex-matched healthy controls under strict anticontamination protocols. A lifestyle questionnaire was administered to assess MP exposure-related habits, revealing that PD patients reported more frequent use of disposable plastic products and bottled water consumption, suggesting greater environmental exposure. Pyrolysis-gas chromatography-mass spectrometry (Py-GC/MS), laser direct infrared imaging (LDIR) and scanning electron microscopy (SEM) were used to quantify and characterize the MPs. Five polymer types-polyethylene (PE), polystyrene (PS), polyvinyl chloride (PVC), polypropylene (PP) and nylon-66 (PA66)-were detected in the sample. The total MP burden was significantly greater in PD patients than in controls (21.36 ± 8.42 vs. 13.56 ± 5.92 μg/g; p < 0.01), with the greatest increases observed for PVC (1.49-fold), PP (2.74-fold) and PA66 (6.62-fold), whereas the PE and PS levels were not significantly different. LDIR and SEM analyses revealed diverse particle morphologies, with most polymers appearing as granular particles. In vitro assays further revealed that PVC and PP microplastics induced dopaminergic neuron apoptosis and increased the level of phosphorylated α-synuclein (p-α-syn), providing support for their potential neurotoxicity. Together, these findings indicate elevated blood MP levels in PD patients and offer preliminary evidence linking polymer exposure with PD-related neuronal vulnerability.
Sign in to start a discussion.
More Papers Like This
Microplastic Exposure and the of Parkinson’s Disease
This review examines evidence linking microplastic exposure to Parkinson's disease pathology, noting that animal studies show microplastics can decrease dopaminergic neurons and impair motor function through mechanisms resembling the disease's progression.
Plastamination: A Rising Concern for Parkinson's Disease
This paper examined the potential link between widespread plastic pollution and the rising incidence of Parkinson's disease, which is growing faster than expected based on aging populations alone. Researchers highlighted how microplastics can cross the blood-brain barrier and may trigger neuroinflammation and oxidative stress associated with neurodegeneration. The study suggests that the environmental accumulation of plastic waste, termed 'plastamination,' deserves serious investigation as a possible contributing factor to neurological conditions.
Micro-nanoplastics and Parkinson’s disease: evidence and perspectives
Researchers reviewed growing evidence linking micro- and nanoplastic exposure to Parkinson's disease, a degenerative brain condition. Lab studies suggest these particles may accelerate disease by promoting the misfolding of a key brain protein (alpha-synuclein), triggering inflammation, and damaging mitochondria — though large-scale human studies are still needed to establish causation and define safe exposure thresholds.
Do microplastics play a role in the pathogenesis of neurodegenerative diseases? Shared pathophysiological pathways for Alzheimer’s and Parkinson’s disease
This review explores the emerging connection between microplastic exposure and neurodegenerative diseases such as Alzheimer's and Parkinson's, identifying shared pathophysiological pathways. Researchers found that microplastics can cross the blood-brain barrier and may trigger oxidative stress, neuroinflammation, and protein aggregation, which are hallmarks of these conditions. The study suggests that chronic microplastic exposure could be a contributing environmental factor in neurodegeneration, though direct causal evidence in humans is still lacking.
The role of microplastics exposure in Alzheimer’s and Parkinson’s disease
Researchers reviewed the mechanistic links between microplastic and nanoplastic exposure and the two most common neurodegenerative diseases — Alzheimer's and Parkinson's — finding evidence that oxidative stress, neuroinflammation, blood-brain barrier disruption, and protein aggregation are key pathways connecting plastic pollution to neurodegeneration.